Deadline to submit articles for InWomen’s Annotated Bibliography approaching

New additions to the InWomen’s Annotated Bibliography will be promoted at the upcoming conference in Montreal, Canada on June 16, 2017.

Please submit articles no later than Monday, May 22, 2017 here: https://goo.gl/forms/3aFpNj1vveSEj4jo1

The submission process takes about a minute!

Register  for the InWomen’s Conference at https://www.regonline.com/InWomens2017Conf

 

 

Advertisements

Call for Submissions: InWomen’s Annotated Bibliography

10275_inwomenslogo_10years

Hotel Bonaventure
Montreal, Canada
June 16, 2017

New additions to the InWomen’s Annotated Bibliography will be promoted at the upcoming conference in Montreal, Canada on June 16, 2017.

It’s that time of year again! We are compiling a list of references with accompanying short summaries of seminal articles in the field of substance use related to women, children, youth, LGBT+ individuals, and gender differences around the world. Articles should have a treatment or prevention component. We are requesting that you submit any publications from your research or papers from outside your group published between May 2016-present that you think are going to have a significant impact on the field for inclusion in the 2017 Annotated Bibliography.  The Annotated Bibliography will be available year round, in Excel form. All submissions will be reviewed by InWomen’s prior to approval for inclusion.

Please submit articles here: https://goo.gl/forms/3aFpNj1vveSEj4jo1

The submission process takes about a minute!

Register  for the InWomen’s Conference at https://www.regonline.com/InWomens2017Conf

Introducing 2017 Panel II Speakers

Panel II: Substance Use Disorder in Women and Families

ADunlop_pic.jpgSpeaker IV: Dr. Adrian Dunlop, MBBS, PhD, GDipEpiBiostat, FAChAM, Area Director and Senior Staff Specialist, Drug and Alcohol Clinical Services for the Hunter New England Local Health District; Chief Addiction Medical Specialist in the NSW Ministry of Health; Conjoint Professor in the School of Medicine and Public Health at the University of Newcastle.

Presentation Title: Implementing a Parenting Intervention for Mothers and Fathers in Substance Use Treatment Programs 

Bio: Dr. Adrian Dunlop, MBBS, PhD, GDipEpiBiostat, FAChAM, is Area Director and Senior Staff Specialist, Drug and Alcohol Clinical Services for the Hunter New England Local Health District, Chief Addiction Medicine Specialist in the NSW Ministry of Health, and Conjoint Professor in the Schools of Medicine and Public Health at the University of Newcastle. He is a Foundation Fellow of the Australasian Chapter of Addiction Medicine (FAChAM) in the Royal Australasian College of Physicians, Past-President of the Australasian Professional Society on Alcohol and other Drugs (APSAD), member of the College of Problems on Drug Dependence (USA), Society for the Study of Addiction (UK), and the International Society for Addiction Medicine. In 2005, he was awarded a Churchill Fellowship to investigate the treatment of opiate dependence in pregnancy. In 2010 he was awarded Clinical Leader of the Year by Hunter New England Health. In 2014 he was awarded the APSAD clinician award for excellence in Science, research and practice in the drug and alcohol field and was a 2015 James Rankin orator for APSAD. He has over two decades of experience in the drug and alcohol field, over 140 publications including 73 peer reviewed journal articles, 8 book chapters and a co-author on Australian guidelines on addiction management, and attracted on 30 grants including over $A14 million in collaborative competitive research funding.

dell.jpg 

Speaker V: Dr. Colleen Dell, PhD, Centennial Enhancement Chair in One Health and Wellness; Professor of Sociology and Public Health at the University of Saskatchewan; Senior Research Associate with the Canadian Centre on Substance Abuse.

Presentation Title: Identity, Culture and Healing from Opioid Use Disorder and other Addictions: Indigenous Women in Canada 

Bio:  Dr. Colleen Dell, PhD, is a Centennial Enhancement Chair in One Health and Wellness; Professor of Sociology and Public Health at the University of Saskatchewan; and Senior Research Associate with the Canadian Centre on Substance Abuse. Dr. Dell’s research interests include identity and stigma and their relationship to healing from drug addiction, substance abuse treatment and programming, self-harm among women and girls, the connection between youth resiliency and volatile substance misuse, animal assisted interventions as a healing approach to addictions and mental health, harm reduction, campus prevention initiatives, and research methodology and evaluation. Dr. Dell’s research areas are specific to Aboriginal populations, criminalized women, and drug using populations. Her research studies are grounded in a community-based participatory approach. Prior to her arrival at the University of Saskatchewan, Dr. Dell worked extensively at the community and national levels, including with the Elizabeth Fry Society of Manitoba, Correctional Service Canada, and the Senate of Canada.

Kimberly Page edited 1.jpg 

Speaker VI: Dr. Kimberly Page, PhD, Professor and Chief of Epidemiology, Biostatistics, and Preventive Medicine in the Department of Internal Medicine at the University of New Mexico’s Health Sciences Center

Presentation Title: Who is a SMARTgirl? Demographics, Risk and HIV among Cambodian Female Entertainment and Sex Workers Participating in an HIV Risk Reduction Intervention in Cambodia 

Bio: Dr. Kimberly Page, PhD, is a Professor and Chief of Epidemiology, Biostatistics, and Preventive Medicine in the Department of Internal Medicine at the University of New Mexico’s Health Sciences Center. Dr. Page leads nationally and internationally recognized research on HIV and viral hepatitis prevention in underserved and vulnerable populations, including people who inject drugs (PWID), and women engaged in transactional sex. She likes to say that her ‘laboratory’ is in the community, and embraces the challenges of working with hard-to-reach populations with her work in the U.S. and internationally.  In addition to leading the country’s first trial testing a prophylactic HCV vaccine in PWID, she has launched new studies integrating HCV treatment and prevention in rural and urban New Mexico.  She also collaborates with leading researchers and public health groups in the U.S and other countries to better understand and deliver global health knowledge and HIV and HCV prevention.  She leads a multidisciplinary team of researchers in Cambodia where they recently implemented a large multi-level HIV prevention intervention aimed at reducing HIV risk due to in female sex and entertainment workers in 10 provinces.  This project was an ‘implementation science’ project that included targeted interventions to reduce sexual risk, amphetamine type stimulant use, and economic opportunities.

Introducing 2017 Panel I Speakers

Panel I: Prenatal Cannabis Use and Neonatal Outcomes

 

IngunnOleaLund.jpgSpeaker I: Dr. Ingunn Lund, PhD, MSc, Senior Researcher at the Norwegian Institute of Public Health

Presentation Title: Prenatal Exposure to Alcohol and Child Internalizing and Externalizing Problems: An Extended Sibling Control Study  

Bio: Dr. Ingunn Lund is a Senior Researcher at the Norwegian Institute of Public Health, and she received her MSc in Social Psychology from the Norwegian University of Science and Technology, and her PhD from the Medical Faculty, University of Oslo. She spent a year in the US as a Fulbright scholar. Her main research interests include consequences for children from prenatal exposure to legal and illegal substances, and from parental substance use and abuse. She is the Principal Investigator for a project where the primary aim is to investigate the putative long-term effects of parental drinking in regard to their children’s mental health, substance use, and workforce non-participation using combined survey and register data that includes long-term follow up of more than 8,000 children and parent dyads/triads.

 

CelinaValenciaSpeaker II: Dr. Celina Irinea Valencia, DrPH, Policy Advisor to the Office of Migrant Health for the Mexico Ministry of Health

Presentation Title: Prenatal Cannabis Exposure: Current State of Evidence 

Bio: Dr. Celina Irinea Valencia, DrPH, is a Policy Advisor to the Office of Migrant Health for the Mexico Ministry of Health. Dr. Valencia earned her Doctorate of Public Health in Public Health Policy and Management at the Mel and Enid Zuckerman College of Public Health at the University of Arizona in Tucson, Arizona. Utilizing a social epidemiological approach, Dr. Valencia considers the ways which social forces influence health trends. Specifically, Dr. Valencia focuses on the social realities that are unique to the United States/Mexico border region. Dr. Valencia has published on structural barriers for accessing medical marijuana in the United States, and the association of medical marijuana laws and opioid drug use rates in Arizona. Dr. Valencia was born and raised in a rural town located on the Arizona/Mexico border. Living at the cultural, linguistic, and economic intersection of two worlds has developed a distinct lens that guides Dr. Valencia’s research inquiries.

 

Hanan cropped

Speaker III: Dr. Hanan El Marroun, PhD, MSc, Assistant Professor at Erasmus University Medical Center

Presentation Title: Prenatal Cannabis Exposure and Child Neurodevelopment: A Tolerated Matter 

Bio:  Dr. Hanan El Marroun, PhD, MSc, is an Assistant Professor at Erasmus University Medical Center. Dr. Marroun has a background in both neurosciences as epidemiology, which she combines in her research. Her research line has mainly focused on the short- and long-term neurodevelopmental consequences of prenatal exposure to cannabis and maternal smoking. Next to this research line, she investigates the neurodevelopmental consequences of prenatal exposure to antidepressants and depression. Further, Dr. El Marroun is currently collaborating in studies examining prenatal exposure to pain medication (such as acetaminophen) and child neurodevelopment. In terms of child neurodevelopment, her focus is on cognition, emotional and behavioral functioning and structural neuroimaging.

 

 

Top 5 Reasons You Should Attend InWomen’s

m,

Top 5 Reasons You Should Attend

Before we dive into why you should attend, let’s first talk about what the InWomen’s Conference is. The International Women’s and Children’s Health and Gender (InWomen’s) Group is a multidisciplinary forum addressing all aspects of substance use among women, children, and youth. InWomen’s holds a yearly conference to bring together the smartest minds in the field of gender research and substance use.

 Now, here are 5 reasons we’re calling the InWomen’s Conference a must-attend event:

It’s the ONLY conference in the world focusing on women and addiction. Nowhere else can you find a conference focused on gender inequality, reaching women who use substances, increasing HIV testing, and treating vulnerable women and adolescents globally. This year, we will set an agenda for the next decade of addiction research in the field of substance use among women, children, and youth.

 We’re hosting a celebration to commemorate our 10th year. Mingle with researchers, students, and others at our evening celebration! We’ll have delicious hors d’oeuvres and a cash bar, a selfie booth to document the fun times, dancing, and Montreal native, DJ TIZI.

 You’ll meet top-rated researchers from around the globe. We’ll have presentations, panel sessions, and discussion forums with some of the smartest minds in the field. View the full lineup here.

 The conference takes place in the heart of downtown Montreal. The venue is connected to the underground city (Central Station), the business district (Old Montreal), and major attractions, making it the perfect place to start your exploration of the city.

 You can combine InWomen’s with your trip to the Annual Meeting of the College on Problems of Drug Dependence. InWomen’s conveniently takes place the day before CPDD, and just before the NIDA International Forum, so you can easily combine your trip and save on travel.

Register Now

 

Register Today for the 10th Annual InWomen’s Conference

10275_inwomenslogo_10years

 

10th Annual International Women’s and Children’s Health and Gender Group Conference

Friday, 16, June 2017, 9:00 to 17:00
Hotel Bonaventure, Montreal, Canada

This very special 10th year meeting will be held one day prior to the 79th Annual Meeting of the College on Problems of Drug Dependence and just before the NIDA International Forum.

Register for the InWomen’s Conference at
https://www.regonline.com/InWomens2017Conf

Meeting Agenda

8:00  Registration and Check-In
9:00  Welcome:

  • Wendee Wechsberg, PhD, Conference Chair; Director, RTI Global Gender Center
  • Loretta Finnegan, MD, CPDD Executive Officer
  • Claire Sterk, PhD, President of Emory University via Video

Opening: Thema Bryant-Davis, PhD, Psychologist, Minister, Sacred Artist

10:15 Panel Session I: Prenatal Cannabis Use and Neonatal Outcomes

  • Prenatal Exposure to Alcohol and Child Internalizing and Externalizing Problems: An Extended Sibling Control Study
    Ingunn Lund, PhD, Senior Researcher, Norwegian Institute of Public Health, Oslo, Norway
  • Prenatal Cannabis Exposure: Current State of Evidence
    Celina Irinea Valencia, ABD
    , Doctoral Candidate in Public Health Policy and Management, University of Arizona, Tucson, Arizona, USA
  • Prenatal Cannabis Exposure and Child Neurodevelopment: A Tolerated Matter
    Hanan El Marroun, PhD, Assistant Professor, Erasmus Medical Center, Rotterdam, Netherlands

11:15 Topical Discussion Tables

  1. Caring for Women with Co-occurring Mental Health Conditions in Primary Care Settings
  2. Cannabis, Opioids, and Other Drug Use and Neonatal Outcomes
  3. Global Perspective on Women’s Access to Treatment: Stigma, Discrimination, and other Critical Issues
  4. LGBTQ and Substance Use: Factors Associated with Use and Recovery
  5. Women and Substance Use, HIV, IPV, and Sex Trafficking
  6. Gender and Culturally-centered Treatment Approaches for Indigenous People with Substance Use Disorder
  7. The Next 10 Years: Critical Issues and Moving the Field Forward Faster

12:45 Lunch and Poetry: Thema Bryant-Davis, PhD

13:45 Panel Session II: Substance Use Disorder in Women and Families

  • Implementing a Parenting Intervention for Mothers and Fathers in Substance Use Treatment Programs
    Adrian Dunlop, PhD, FAChAM, GradDipEpi&Biostat, Area Director, NSW Health, North Sydney, Australia
  • Identity, Culture and Healing from Opioid Use Disorder and other Addictions: Indigenous Women in Canada
    Colleen Dell, PhD, Addition Research Chair in Substance Abuse, University of Saskatchewan, Saskatoon, Canada
  • Who is a SMARTgirl? Demographics, Risk and HIV among Cambodian Female Entertainment and Sex Workers Participating in an HIV Risk Reduction Intervention in Cambodia
    Kimberly Page, PhD, MPH, MS, Tenured Professor and Chief of Epidemiology, Biostatistics & Preventive Medicine University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA

14:45 Poster Session

16:15 Closing: Strategic Planning for the Way Forward

20:00  InWomen’s 10th Year Evening Celebration

 

Conference Registration Fees

InWomen’s 10th Year Evening Celebration Fee: $15 per person

Online

  • Full Conference Fee Level (Registrants from high- or middle-income countries and non-students) *will receive InWomen’s 10th Year shirt: $150
  • Reduced Conference Fee Level (Students and registrants from low-income countries): $75

On-site

  • Full Conference Fee Level (Registrants from high- or middle-income countries and non-students) *will receive InWomen’s 10th Year shirt: $200
  • Reduced Conference Fee Level (Students and registrants from low-income countries): $100

*Online registration is available until May 30, 2017. Lunch and discussion table choices may not be available if you opt to register on-site.

 

 

How Iceland Got Teens to Say No to Drugs

lead_960

It’s a little before 3 p.m. on a sunny Friday afternoon and Laugardalur Park, near central Reykjavik, looks practically deserted. There’s an occasional adult with a stroller, but the park’s surrounded by apartment blocks and houses, and school’s out—so where are all the kids?

Full Article: https://www.theatlantic.com/health/archive/2017/01/teens-drugs-iceland/513668/